Glutathione S -transferase (GST) M1, but not GSTT1, genotype influences plasma proteomic profiles in Caucasian and East Asian young adults

Journal of Proteome Research

Volumn 11, Issue 10, 2012, Pages 5022-5033

  Fischer, Karina ^a,b   Da Costa, Laura A ^a   García Bailo, Bibiana ^a   Borchers, Christoph H ^c   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

acute phase proteins; blood pressure; C3; coagulation; complement activation; complement component 3; complement system; glutathione S transferases; GSTM1; GSTT1; HDL metabolism; inflammation; innate immunity; plasma proteins; proteomics

Indexed keywords

ADIPONECTIN; AFAMIN; ALPHA 1 ANTITRYPSIN; ALPHA 1B GLYCOPROTEIN; ALPHA 2 ANTIPLASMIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANGIOTENSINOGEN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN C1; APOLIPOPROTEIN L1; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C9; FIBRONECTIN; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HEMOPEXIN; HEPARIN COFACTOR II; KININOGEN I; PLASMA PROTEIN; PLASMINOGEN; PREALBUMIN; PROTEOME; RETINOL BINDING PROTEIN 4; SERUM AMYLOID P; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITRONECTIN; ZINC ALPHA 2 GLYCOPROTEIN;

ADULT; ARTICLE; ASIAN; BLOOD SAMPLING; CAUCASIAN; ETHNICITY; FEMALE; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY BASED MULTIPLE REACTION MONITORING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; BLOOD PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAR EAST; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; PROTEOMICS; SEQUENCE DELETION; YOUNG ADULT;

EID: 84867453374     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3005887     Document Type: Article

References (72)

1. Boyer, T. D. The glutathione S-transferases: an update Hepatology (Baltimore, Md) 1989, 9 (3) 486-496
2. Sheehan, D.; Meade, G.; Foley, V. M.; Dowd, C. A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily Biochem. J. 2001, 360 (Pt 1) 1-16
3. Xu, S.; Wang, Y.; Roe, B.; Pearson, W. R. Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion J. Biol. Chem. 1998, 273 (6) 3517-3527
4. Pemble, S.; Schroeder, K. R.; Spencer, S. R.; Meyer, D. J.; Hallier, E.; Bolt, H. M.; Ketterer, B.; Taylor, J. B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism Biochem. J. 1994, 300 (Pt 1) 271-276
5. Davies, M. H.; Elias, E.; Acharya, S.; Cotton, W.; Faulder, G. C.; Fryer, A. A.; Strange, R. C. GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis Gut 1993, 34 (4) 549-553
6. Ginsberg, G.; Smolenski, S.; Hattis, D.; Guyton, K. Z.; Johns, D. O.; Sonawane, B. Genetic Polymorphism in Glutathione Transferases (GST): Population distribution of GSTM1, T1, and P1 conjugating activity J. Toxicol. Environ. Health B Crit. Rev. 2009, 12 (5-6) 389-439
7. Bruhn, C.; Brockmoller, J.; Kerb, R.; Roots, I.; Borchert, H. H. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1) Biochem. Pharmacol. 1998, 56 (9) 1189-1193
8. Rebbeck, T. R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiol. Biomarkers Prev. 1997, 6 (9) 733-743
9. Piacentini, S.; Polimanti, R.; Porreca, F.; Martinez-Labarga, C.; De Stefano, G. F.; Fuciarelli, M. GSTT1 and GSTM1 gene polymorphisms in European and African populations Mol. Biol. Rep. 2011, 38 (2) 1225-1230
10. Wilce, M. C.; Parker, M. W. Structure and function of glutathione S-transferases Biochim. Biophys. Acta 1994, 1205 (1) 1-18
11. Habig, W. H.; Pabst, M. J.; Jakoby, W. B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation J. Biol. Chem. 1974, 249 (22) 7130-7139
12. Ginsberg, G.; Smolenski, S.; Neafsey, P.; Hattis, D.; Walker, K.; Guyton, K. Z.; Johns, D. O.; Sonawane, B. The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes J. Toxicol. Environ. Health B Crit. Rev. 2009, 12 (5-6) 307-333
13. Block, G.; Shaikh, N.; Jensen, C. D.; Volberg, V.; Holland, N. Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1 Am. J. Clin. Nutr. 2011, 94 (3) 929-937
14. Zhao, Y.; Marotta, M.; Eichler, E. E.; Eng, C.; Tanaka, H. Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes PLoS Genet. 2009, 5 (5) e1000472
15. Tan, K. L.; Board, P. G. Purification and characterization of a recombinant human Theta-class glutathione transferase (GSTT2-2) Biochem. J. 1996, 315 (Pt 3) 727-732
16. Prohaska, J. R. The glutathione peroxidase activity of glutathione S-transferases Biochim. Biophys. Acta 1980, 611 (1) 87-98
17. Beckett, G. J.; Hayes, J. D. Glutathione S-transferases: biomedical applications Adv. Clin. Chem. 1993, 30, 281-380
18. Tang, J. J.; Wang, M. W.; Jia, E. Z.; Yan, J. J.; Wang, Q. M.; Zhu, J.; Yang, Z. J.; Lu, X.; Wang, L. S. The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study Mol. Biol. Rep. 2010, 37 (1) 405-410
19. Cho, S. G.; Lee, Y. H.; Park, H. S.; Ryoo, K.; Kang, K. W.; Park, J.; Eom, S. J.; Kim, M. J.; Chang, T. S.; Choi, S. Y.; Shim, J.; Kim, Y.; Dong, M. S.; Lee, M. J.; Kim, S. G.; Ichijo, H.; Choi, E. J. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1 J. Biol. Chem. 2001, 276 (16) 12749-12755
20. Hosono, N.; Kishi, S.; Iho, S.; Urasaki, Y.; Yoshida, A.; Kurooka, H.; Yokota, Y.; Ueda, T. Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line Cancer Sci. 2010, 101 (3) 767-773
21. Chen, H.; Juchau, M. R. Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro Biochem. J. 1998, 336 (Pt 1) 223-226
22. Cahill, L. E.; Fontaine-Bisson, B.; El-Sohemy, A. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency Am. J. Clin. Nutr. 2009, 90 (5) 1411-1417
23. Listowsky, I.; Abramovitz, M.; Homma, H.; Niitsu, Y. Intracellular binding and transport of hormones and xenobiotics by glutathione-S-transferases Drug Metab. Rev. 1988, 19 (3-4) 305-318
24. Shen, Y.; Kim, J.; Strittmatter, E. F.; Jacobs, J. M.; Camp, D. G.; Fang, R.; Tolie, N.; Moore, R. J.; Smith, R. D. Characterization of the human blood plasma proteome Proteomics 2005, 5 (15) 4034-4045
25. Hortin, G. L.; Sviridov, D.; Anderson, N. L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance Clin. Chem. 2008, 54 (10) 1608-1616
26. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1 (11) 845-867
27. Salgado, F. J.; Arias, P.; Canda-Sanchez, A.; Nogueira, M. Acute phase proteins as biomarkers of disease: from bench to clinical practice. In Acute phase proteins as early non-specific biomarkers of human and veterinary diseases; Veas, F., Ed.; InTech: Rijeka, Croatia, 2011; pp 127-174.
28. Anderson, L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol. 2005, 563 (Pt 1) 23-60
29. Kuzyk, M. A.; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-1877
30. Garcia-Bailo, B.; Brenner, D. R.; Nielsen, D.; Lee, H. J.; Domanski, D.; Kuzyk, M.; Borchers, C. H.; Badawi, A.; Karmali, M. A.; El-Sohemy, A. Dietary patterns and ethnicity are associated with distinct plasma proteomic groups Am. J. Clin. Nutr. 2012, 95 (2) 352-361
31. Willett, W. C.; Stampfer, M. J.; Underwood, B. A.; Speizer, F. E.; Rosner, B.; Hennekens, C. H. Validation of a dietary questionnaire with plasma carotenoid and alpha-tocopherol levels Am. J. Clin. Nutr. 1983, 38 (4) 631-639
32. Cahill, L.; Corey, P. N.; El-Sohemy, A. Vitamin C deficiency in a population of young Canadian adults Am. J. Epidemiol. 2009, 170 (4) 464-471
33. Ainsworth, B. E.; Haskell, W. L.; Leon, A. S.; Jacobs, D. R., Jr.; Montoye, H. J.; Sallis, J. F.; Paffenbarger, R. S., Jr. Compendium of physical activities: classification of energy costs of human physical activities Med. Sci. Sports Exerc. 1993, 25 (1) 71-80
34. Cornelis, M. C.; El-Sohemy, A.; Campos, H. GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction Am. J. Clin. Nutr. 2007, 86 (3) 752-758
35. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-588
36. Kim, J. O.; Meller, C. W. Factor Analysis: Statistical Methods and Practical Issues; Sage Publications, Inc.: Newbury Park, CA, 1987.
37. Strange, R. C.; Jones, P. W.; Fryer, A. A. Glutathione S-transferase: genetics and role in toxicology Toxicol. Lett. 2000, 112-113, 357-363
38. Lin, H. J.; Probst-Hensch, N. M.; Louie, A. D.; Kau, I. H.; Witte, J. S.; Ingles, S. A.; Frankl, H. D.; Lee, E. R.; Haile, R. W. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas Cancer Epidemiol. Biomarkers Prev. 1998, 7 (8) 647-652
39. London, S. J.; Yuan, J. M.; Chung, F. L.; Gao, Y. T.; Coetzee, G. A.; Ross, R. K.; Yu, M. C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China Lancet 2000, 356 (9231) 724-729
40. Meyer, D. J. Significance of an unusually low Km for glutathione in glutathione transferases of the alpha, mu and pi classes Xenobiotica 1993, 23 (8) 823-834
41. Board, P. G.; Coggan, M.; Wilce, M. C.; Parker, M. W. Evidence for an essential serine residue in the active site of the Theta class glutathione transferases Biochem. J. 1995, 311 (Pt 1) 247-250
42. Caccuri, A. M.; Antonini, G.; Board, P. G.; Parker, M. W.; Nicotra, M.; Lo, B. M.; Federici, G.; Ricci, G. Proton release on binding of glutathione to alpha, Mu and Delta class glutathione transferases Biochem. J. 1999, 344 (Pt 2) 419-425
43. Hayes, J. D.; Strange, R. C. Glutathione S-transferase polymorphisms and their biological consequences Pharmacology 2000, 61 (3) 154-166
44. Buzio, L.; De, P. G.; Mozzoni, P.; Tondel, M.; Buzio, C.; Franchini, I.; Axelson, O.; Mutti, A. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals Occup. Environ. Med. 2003, 60 (10) 789-793
45. Strange, R. C.; Faulder, C. G.; Davis, B. A.; Hume, R.; Brown, J. A.; Cotton, W.; Hopkinson, D. A. The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes Ann. Hum. Genet. 1984, 48 (Pt 1) 11-20
46. Sherratt, P. J.; Pulford, D. J.; Harrison, D. J.; Green, T.; Hayes, J. D. Evidence that human class Theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes Alpha, Mu and Pi GST in human Biochem. J. 1997, 326 (Pt 3) 837-846
47. Pemble, S. E.; Taylor, J. B. An evolutionary perspective on glutathione transferases inferred from class-theta glutathione transferase cDNA sequences Biochem. J. 1992, 287 (Pt 3) 957-963
48. Shah, T.; Newcombe, P.; Smeeth, L.; Addo, J.; Casas, J. P.; Whittaker, J.; Miller, M. A.; Tinworth, L.; Jeffery, S.; Strazzullo, P.; Cappuccio, F. P.; Hingorani, A. D. Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction Circ. Cardiovasc. Genet. 2010, 3 (5) 436-444
49. Stommel, M.; Schoenborn, C. A. Variations in BMI and prevalence of health risks in diverse racial and ethnic populations Obesity (Silver Spring) 2010, 18 (9) 1821-1826
50. Walport, M. J. Complement. First of two parts N. Engl. J. Med. 2001, 344 (14) 1058-1066
51. Hertle, E.; van Greevenbroek, M. M.; Stehouwer, C. D. Complement C3: an emerging risk factor in cardiometabolic disease Diabetologia 2012, 55 (4) 881-884
52. Markiewski, M. M.; Nilsson, B.; Ekdahl, K. N.; Mollnes, T. E.; Lambris, J. D. Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007, 28 (4) 184-192
53. Muscari, A.; Bozzoli, C.; Puddu, G. M.; Sangiorgi, Z.; Dormi, A.; Rovinetti, C.; Descovich, G. C.; Puddu, P. Association of serum C3 levels with the risk of myocardial infarction Am. J. Med. 1995, 98 (4) 357-364
54. Onat, A.; Can, G.; Rezvani, R.; Cianflone, K. Complement C3 and cleavage products in cardiometabolic risk Clin. Chim. Acta 2011, 412 (13-14) 1171-1179
55. Bene, L.; Fust, G.; Fekete, B.; Kovacs, A.; Horvath, L.; Prohaszka, Z.; Miklos, K.; Palos, G.; Daha, M.; Farkas, H.; Varga, L. High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohns disease than ulcerative colitis Dig. Dis. Sci. 2003, 48 (6) 1186-1192
56. Muscari, A.; Antonelli, S.; Bianchi, G.; Cavrini, G.; Dapporto, S.; Ligabue, A.; Ludovico, C.; Magalotti, D.; Poggiopollini, G.; Zoli, M. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population Diabetes Care 2007, 30 (9) 2362-2368
57. Pangburn, M. K.; Muller-Eberhard, H. J. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3 Ann. N.Y. Acad. Sci. 1983, 421, 291-298
58. Fredslund, F.; Jenner, L.; Husted, L. B.; Nyborg, J.; Andersen, G. R.; Sottrup-Jensen, L. The structure of bovine complement component 3 reveals the basis for thioester function J. Mol. Biol. 2006, 361 (1) 115-127
59. Perricone, C.; De, C. C.; Giacomelli, R.; Greco, E.; Cipriani, P.; Ballanti, E.; Novelli, L.; Perricone, R. Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications Int. J. Immunopathol. Pharmacol. 2011, 24 (1) 63-68
60. Pangburn, M. K. Spontaneous reformation of the intramolecular thioester in complement protein C3 and low temperature capture of a conformational intermediate capable of reformation J. Biol. Chem. 1992, 267 (12) 8584-8590
61. Datta, S. K.; Kumar, V.; Ahmed, R. S.; Tripathi, A. K.; Kalra, O. P.; Banerjee, B. D. Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients Indian J. Biochem. Biophys. 2010, 47 (2) 100-103
62. Mold, C.; Gewurz, H.; Du Clos, T. W. Regulation of complement activation by C-reactive protein Immunopharmacology 1999, 42 (1-3) 23-30
63. Onat, A.; Hergenc, G.; Ayhan, E.; Ugur, M.; Can, G. Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks Clin. Chem. Lab. Med. 2009, 47 (11) 1389-1394
64. Onat, A.; Hergenc, G. Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk Metabolism 2011, 60 (4) 499-512
65. Davidsson, P.; Hulthe, J.; Fagerberg, B.; Camejo, G. Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins Arterioscler. Thromb. Vasc. Biol. 2010, 30 (2) 156-163
66. Khovidhunkit, W.; Kim, M. S.; Memon, R. A.; Shigenaga, J. K.; Moser, A. H.; Feingold, K. R.; Grunfeld, C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host J. Lipid Res. 2004, 45 (7) 1169-1196
67. Onat, A.; Hergenc, G.; Can, G.; Kaya, Z.; Yuksel, H. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population Metabolism 2010, 59 (5) 628-634
68. Zhaorigetu, S.; Wan, G.; Kaini, R.; Jiang, Z.; Hu, C. A. ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death Autophagy 2008, 4 (8) 1079-1082
69. Brasier, A. R.; Recinos, A., III; Eledrisi, M. S. Vascular inflammation and the renin-angiotensin system Arterioscler. Thromb. Vasc. Biol. 2002, 22 (8) 1257-1266
70. Cruz-Gonzalez, I.; Corral, E.; Sanchez-Ledesma, M.; Sanchez-Rodriguez, A.; Martin-Luengo, C.; Gonzalez-Sarmiento, R. An association between resistant hypertension and the null GSTM1 genotype J. Hum. Hypertens. 2009, 23 (8) 556-558
71. Fernandez-Real, J. M. Genetic predispositions to low-grade inflammation and type 2 diabetes Diabetes Technol. Ther. 2006, 8 (1) 55-66
72. Liang, X.; Lin, T.; Sun, G.; Beasley-Topliffe, L.; Cavaillon, J. M.; Warren, H. S. Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages J. Leukoc. Biol. 2009, 86 (2) 229-235